毛细支气管炎的家庭护理:一项系统综述
该系统综述评估毛细支气管炎家庭住院(HAH)的可行性、可接受性和安全性及成本影响。
要点
- 家庭氧疗在毛细支气管炎婴儿中可行且安全,不良事件率0.6%,死亡率0。
- 家庭氧疗使用率70%-82%, caregivers可接受。
- 成本研究显示节省,但仅计入医院成本。
核心结论
- 证据支持家庭氧疗可行、可接受且安全,但成本效益证据有限。
研究设计与样本
- 系统综述,检索Ovid Medline、Embase、Pubmed、Cochrane Library、CINAHL和Web of Science,纳入2000年以来英文研究,包括随机对照试验、回顾性审计和前瞻性观察试验。
主要发现
- HOT使用率70%-82%,在高原和海平面均能成功完成。
- 2项定性研究报告了照护者接受度。
- 1257例患者中报告7例不良事件(0.6%),死亡率0。
- 成本研究显示节省,但仅包括医院成本。
关键数值与推荐
- 纳入研究为接受HAH(氧疗、鼻胃管喂养、远程监测)的毛细支气管炎婴儿。
- 仅1篇关于鼻胃管喂养的摘要未完全符合纳入标准,未发现远程监测研究。
临床怎么用
- 对于符合条件的毛细支气管炎婴儿,家庭氧疗可作为住院的替代方案,但需评估成本效益和长期影响。
- 鼻胃管喂养支持和远程监测的家庭护理模式需进一步研究。
局限性
- 研究数量少,设计异质,质量不一。
- 无足够效能的随机对照试验。
- 成本研究仅计入医院成本,未考虑社会成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Bronchiolitis is the leading cause of pediatric hospital admissions. Hospital-at-Home (HAH) delivers hospital-level care at home, relieving pressure on the hospital system. OBJECTIVES: We aimed to review the feasibility, acceptability, and safety of HAH for bronchiolitis, and assess the cost-impact to hospitals and society. DATA SOURCES: Ovid Medline, Embase, Pubmed, Cochrane Library, CINAHL, and Web of Science. STUDY SELECTION: Studies (randomized control trials, retrospective audits, prospective observational trials) of infants with bronchiolitis receiving HAH (oxygen, nasogastric feeding, remote monitoring). Studies were limited to English language since 2000. DATA EXTRACTION: We reviewed all studies in duplicate for inclusion, data extraction, and risk of bias. RESULTS: Ten studies met inclusion criteria, all for home oxygen therapy (HOT). One abstract on nasogastric feeding did not meet full inclusion criteria. No studies on remote monitoring were found. HOT appears feasible in terms of uptake (70%-82%) and successful completion, both at altitude and sea-level. Caregiver acceptability was reported in 2 qualitative studies. There were 7 reported adverse events (0.6%) with 0 mortality in 1257 patients. Cost studies showed evidence of savings, although included costs to hospitals only. LIMITATIONS: Small number of studies with heterogenous study design and quality. No adequately powered randomized control studies. CONCLUSIONS: Evidence exists to support HOT as feasible, acceptable, and safe. Evidence of cost-effectiveness remains limited. Further research is needed to understand the relevant impact of HAH versus alternative interventions to reduce oxygen prescribing. Other models of care looking at nasogastric feeding support and remote monitoring should be explored.
引用
- Lawrence J, Walpola R, Boyce SL, et al. Home Care for Bronchiolitis: A Systematic Review. Pediatrics. 2022. PMID: 36065737. doi:10.1542/peds.2022-056603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。